nejm tirzepatide New in the July 3, 2025, issue of NEJM: Exercise after Chemotherapy for Colon Cancer (CHALLENGE phase 3 trial) https://nej.md/4mh5RPL vs. Semaglutide for Obesity (SURMOUNT-5 phase 3b trial) https://nej.md/44ZeMPz Pembrolizumab in Once-Weekly Tirzepatide for Obesity |

With the right medical guidance and a personalized treatment plan, these medications can help support long-term weight management and improved metabolic health

If youre experiencing diarrhea or other digestive issues while taking Tirzepatide, our wellness experts can help adjust your treatment plan, provide dietary guidance, and offer holistic support

How Long Do the Weight Loss Effects Last in Research Models Weight maintenance after cessation of GLP-1 and incretin-class compounds is an active area of investigation

Its supportive care list includes staying well-hydrated, eating soluble fiber sources such as oats and psyllium, having smaller and more frequent meals, and avoiding high-fat foods during the adjustment phase